Published Date: 13 Mar 2023
Among other things, international students seek connections and advice on how to better compete by supporting community groups.
Read Full NewsA meta-analysis identifies impaired effort-based decision making across psychiatric disorders, pointing to actionable targets for improving motivation and functional outcomes.
Comments on a Medscape feature push past ideology to ask what evidence, oversight, and safeguards should be available for patients who choose assisted death.
Patients aged 70 years or older stand to benefit from adjuvant chemotherapy for triple-negative breast cancer, but the majority do not receive it.
Researchers conducted a systematic review and meta-analysis for studies of acute myeloid leukemia patients with a median age less than 70 treated with HMA plus venetoclax.
Nearly 400 trials and Belgium’s isotope hub signal rapid clinical diversification for radioligand therapy — but policy, funding, and system readiness must follow.
1.
No Cellphone, Brain Cancer Link; Testosterone Paradox; Breast Density and Cancer
2.
Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting
3.
Is Laughter Good for Blood Glucose Control?
4.
Study finds 20 minutes of mindful breathing can rapidly reduce intensity of cancer pain
5.
Nonmelanoma skin cancer has been linked to occupational exposure to solar UVR.
1.
All You Need to Know About Mesna: The Ultimate Guide
2.
Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After
3.
Uncovering Dyscrasia: A Comprehensive Guide to Diagnosis and Treatment
4.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
5.
Uncovering the Reality of Colon Cancer: A Look at Real Images
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
5.
ESMO Breast Cancer 2022: P Reality X- A Restrospective Analysis
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation